These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3356496)

  • 1. Spinal cord mechanisms in amitriptyline responsive restless legs syndrome in Parkinson's disease.
    Sandyk R; Iacono RP; Bamford CR
    Int J Neurosci; 1988 Jan; 38(1-2):121-4. PubMed ID: 3356496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restless legs syndrome and Parkinson's disease: insights into pathophysiology.
    Lang AE
    Clin Neuropharmacol; 1987 Oct; 10(5):476-8. PubMed ID: 3503686
    [No Abstract]   [Full Text] [Related]  

  • 3. Restless legs syndrome outside the blood-brain barrier--exacerbation by domperidone in Parkinson's disease.
    Rios Romenets S; Dauvilliers Y; Cochen De Cock V; Carlander B; Bayard S; Galatas C; Wolfson C; Postuma RB
    Parkinsonism Relat Disord; 2013 Jan; 19(1):92-4. PubMed ID: 22922159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Istradefylline for Restless Legs Syndrome Associated with Parkinson's Disease.
    Nuermaimaiti M; Oyama G; Kasemsuk C; Hattori N
    Tremor Other Hyperkinet Mov (N Y); 2018; 8():521. PubMed ID: 29423337
    [No Abstract]   [Full Text] [Related]  

  • 5. Restless legs syndrome in Korean patients with drug-naïve Parkinson's disease: a nation-wide study.
    Shin HY; Youn J; Yoon WT; Kim JS; Cho JW
    Parkinsonism Relat Disord; 2013 Mar; 19(3):355-8. PubMed ID: 23047004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sleep disorders in Parkinson's disease: REM sleep behaviour disorder and restless legs syndrome].
    Jáuregui-Barrutia A; Tijero-Merino B; Gómez-Esteban JC; Zarranz JJ
    Rev Neurol; 2010 Feb; 50 Suppl 2():S15-9. PubMed ID: 20205137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective treatment of restless legs syndrome by safinamide in Parkinson's disease patients.
    Liguori C; Mercuri NB; Stefani A; Pierantozzi M
    Sleep Med; 2018 Jan; 41():113-114. PubMed ID: 29268951
    [No Abstract]   [Full Text] [Related]  

  • 8. Restless legs syndrome in Parkinson's disease.
    Tan EK; Lum SY; Wong MC
    J Neurol Sci; 2002 Apr; 196(1-2):33-6. PubMed ID: 11959153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of restless legs syndrome, pain, and mood disorders in Parkinson's disease.
    Rana AQ; Qureshi AR; Rahman L; Jesudasan A; Hafez KK; Rana MA
    Int J Neurosci; 2016; 126(2):116-20. PubMed ID: 25469455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of restless legs syndrome is inversely correlated with echogenicity of the substantia nigra in different neurodegenerative movement disorders. a preliminary observation.
    Pedroso JL; Bor-Seng-Shu E; Felicio AC; Braga-Neto P; Dutra LA; de Aquino CC; Ferraz HB; do Prado GF; Teixeira MJ; Barsottini OG
    J Neurol Sci; 2012 Aug; 319(1-2):59-62. PubMed ID: 22632781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome.
    Reuter I; Ellis CM; Ray Chaudhuri K
    Acta Neurol Scand; 1999 Sep; 100(3):163-7. PubMed ID: 10478579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine and the spinal cord in restless legs syndrome: does spinal cord physiology reveal a basis for augmentation?
    Paulus W; Schomburg ED
    Sleep Med Rev; 2006 Jun; 10(3):185-96. PubMed ID: 16762808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restless legs syndrome and periodic leg movements in patients with movement disorders: Specific considerations.
    Högl B; Stefani A
    Mov Disord; 2017 May; 32(5):669-681. PubMed ID: 28186669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restlessness restricted to the perianal region in a patient with Parkinson's disease.
    Okamura M; Suzuki K; Matsubara T; Hirata K
    Parkinsonism Relat Disord; 2018 Jun; 51():117-118. PubMed ID: 29506822
    [No Abstract]   [Full Text] [Related]  

  • 15. Restless legs syndrome in Parkinson's disease: clinical characteristics and biochemical correlations.
    Guerreiro TM; Nishikawa DR; Ferreira LC; Melo HA; Prado RC
    Arq Neuropsiquiatr; 2010 Dec; 68(6):869-72. PubMed ID: 21243243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restless legs syndrome in Parkinson's disease: a case-controlled study.
    Krishnan PR; Bhatia M; Behari M
    Mov Disord; 2003 Feb; 18(2):181-5. PubMed ID: 12539212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of leg restlessness in Parkinson's disease compared with idiopathic Restless Legs Syndrome.
    Zhu XY; Liu Y; Zhang XJ; Yang WH; Feng Y; Ondo WG; Tan EK; Wu YC
    J Neurol Sci; 2015 Oct; 357(1-2):109-14. PubMed ID: 26189051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intertemporal choice in Parkinson's disease and restless legs syndrome.
    Al-Khaled M; Heldmann M; Bolstorff I; Hagenah J; Münte TF
    Parkinsonism Relat Disord; 2015 Nov; 21(11):1330-5. PubMed ID: 26427640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restless legs syndrome in patients with Parkinson's disease: a comparative study on prevalence, clinical characteristics, quality of life and nutritional status.
    Fereshtehnejad SM; Shafieesabet M; Shahidi GA; Delbari A; Lökk J
    Acta Neurol Scand; 2015 Apr; 131(4):211-8. PubMed ID: 25263328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of Restless legs syndrome in patients with Parkinson's disease.
    Nomura T; Inoue Y; Nakashima K
    J Neurol Sci; 2006 Dec; 250(1-2):39-44. PubMed ID: 16899256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.